Quest Diagnostics Inc (NYSE:DGX) over-valued by 11%
| Website | https://www.questdiagnostics.com/ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Fiscal Year End | Dec 31, 2021 |
| Market Cap | $15,887,460,352 |
| Beta | 1.033645 |
| Average Volume | $1,256,940 |
| Last Dividend | 2.3% |
| Price on Feb 28, 2022 | $145.16 |
| Autochartist™ Valuation | $129.45 |
| Conclusion |
11% over-valued |
| Download Report |
